Neurodegeneration is not observed in mice mimicking MeCP2 disorders or in RTT patients, and phenotypic rescue is possible upon Mecp2 re-activation in animal models [6–9], suggesting that successful therapeutic intervention are possible. The gene discussed is MECP2; the disease is Rett syndrome.